Reduced cell turnover in bovine leukemia virus-infected, persistently lymphocytotic cattle.
Although nucleotide analogs like bromodeoxyuridine have been extensively used to estimate cell proliferation in vivo, precise dynamic parameters are scarce essentially because of the lack of adequate mathematical models. Besides recent developments on T cell dynamics, the turnover rates of B lymphocytes are largely unknown particularly in the context of a virally induced pathological disorder. Here, we aim to resolve this issue by determining the rates of cell proliferation and death during the chronic stage of the bovine leukemia virus (BLV) infection, called bovine persistent lymphocytosis (PL). Our methodology is based on direct intravenous injection of bromodeoxyuridine in association with subsequent flow cytometry. By this in vivo approach, we show that the death rate of PL B lymphocytes is significantly reduced (average death rate, 0.057 day(-1) versus 0.156 day(-1) in the asymptomatic controls). Concomitantly, proliferation of the PL cells is also significantly restricted compared to the controls (average proliferation rate, 0.0046 day(-1) versus 0.0085 day(-1)). We conclude that bovine PL is characterized by a decreased cell turnover resulting both from a reduction of cell death and an overall impairment of proliferation. The cell dynamic parameters differ from those measured in sheep, an experimental model for BLV infection. Finally, cells expressing p24 major capsid protein ex vivo were not BrdU positive, suggesting an immune selection against proliferating virus-positive lymphocytes. Based on a comparative leukemia approach, these observations might help to understand cell dynamics during other lymphoproliferative disease such as chronic lymphocytic leukemia or human T-cell lymphotropic virus-induced adult T-cell leukemia in humans.
Debacq
Christophe
C
Molecular and Cellular Biology, FUSAGx, Gembloux, Belgium.
Asquith
Becca
B
Reichert
Michal
M
Burny
Arsène
A
Kettmann
Richard
R
Willems
Luc
L
D000818:Animals; D017209:Apoptosis; D001402:B-Lymphocytes / Q000276:immunology*; D002417:Cattle; D016923:Cell Death; D002455:Cell Division / Q000502:physiology*; D002478:Cells, Cultured; D002908:Chronic Disease; D016583:Enzootic Bovine Leukosis / Q000276:immunology / Q000503:physiopathology* / Q000821:virology; D001909:Leukemia Virus, Bovine / Q000276:immunology / Q000472:pathogenicity*; D008213:Lymphocyte Activation; D008218:Lymphocytosis / Q000276:immunology / Q000503:physiopathology / Q000662:veterinary* / Q000821:virology